Director, Pharma Business Development USA
About us
Waiv, a spin-out of Owkin, exists to catalyze precision medicine with clinical-grade, AI-powered tests that accelerate biomarker discovery and detection, outcome prediction, and treatment-response assessment across oncology. Built on over seven years of validated medical-AI innovation and one of Europe’s largest multi-institutional data networks, we deliver precise, accurate, and fast analyses that support treatment decisions. Through our industry-leading tech and AI stack, and clinically validated, already-deployed AI tests, such as Rlaps
Risk BC, we unlock morphological insights and future-proof both the clinical diagnostic workflow and pharmaceutical R&D pipelines, to ultimately bring scalable precision medicine to patients worldwide.
www.wearewaiv.com
Waiv is seeking a Director, Pharma Business Development to join our fast-growing and dynamic team.
About the role
The Director, Pharma Business Development has the opportunity to grow our business with pharmaceutical companies by generating new leads, securing strategic partnerships, managing key accounts, and contributing to the go-to-market strategy of the company, in order to implement innovative digital pathology diagnostics that improve clinical decision-making and patient outcomes.
In this role you will directly manage your portfolio of work with your key clients and be responsible for identifying and closing new business opportunities with an eye on long-term renewable business with said clients. As part of the global commercial team and reporting to the VP Business Development, you will be key in promoting Waiv’ advanced AI/machine learning technology to enhance biomarker discovery, clinical trials, market access, and commercial efforts in pharma.
The position will require intimate cross-team collaboration with our Data, R&D, Product and strategy, Pathology and Medical, Legal and regulatory teamsDrive revenue growth by engaging major pharmaceutical clients across multip...